Stevens First Principles Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Stevens First Principles Investment Advisors's BMY Position: Q2 2019 in Review
Stevens First Principles Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 4.7% in Q2 2019, selling an estimated $9.04K and leaving 3,931 shares worth $178K. The position accounts for 0.1% of the portfolio, ranked #67.
Stevens First Principles Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 25 quarters since. The position peaked at $285K in Q3 2017. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.
- Stevens First Principles Investment Advisors held 3,931 shares of Bristol-Myers Squibb worth $178K as of Q2 2019.
- Stevens First Principles Investment Advisors sold 194 Bristol-Myers Squibb shares in Q2 2019, an estimated $9.04K.
- Bristol-Myers Squibb made up 0.1% of Stevens First Principles Investment Advisors's portfolio in Q2 2019, its #67 holding.
- Stevens First Principles Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 25 quarters since.
- Stevens First Principles Investment Advisors's Bristol-Myers Squibb position peaked at $285K in Q3 2017.
- 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.
Based on Stevens First Principles Investment Advisors's 13F filing for Q2 2019, filed 22 Jul 2019.